DSIP 10 mg – Sleep Inducing Peptide

Description

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide designed to support deeper, more restorative sleep. Unlike sedative drugs, it works by promoting slow-wave (delta) sleep—the deepest and most restorative phase of the sleep cycle—without forcing sedation.
It normalizes disturbed sleep architecture and affects multiple systems including stress hormones like cortisol.
. DSIP does not cause physical dependence, tolerance, or rebound insomnia, making it distinct from conventional sleep medications.

Side effects and precautions:
Common side effects include mild injection site reactions, occasional next-day fatigue, mild nausea, and changes in dream patterns, which typically resolve within hours to a day.
. If you have PTSD, chronic nightmares, or stress-related sleep disturbance, intensified dreaming from DSIP may be unwanted
. Avoid DSIP if you’re pregnant or breastfeeding, have active autoimmune conditions, or take sedatives or CNS depressants
. Research is limited compared to mainstream sleep aids, so the full side effect profile over long-term use isn’t deeply characterized
.

Recommended dosage:
DSIP is administered by subcutaneous injection 30–60 minutes before bedtime in a typical dose range of 100–300 mcg.
. Dosing should be set by your prescribing provider
. Always follow your doctor’s or pharmacist’s instructions for your individual needs.

This is general information, not medical advice. Talk to your doctor or pharmacist before starting DSIP or if you have questions about how it fits with your health.